No phaseNot yet recruiting

Dexmedetomidine as an Adjuvant to Bupivacaine in Fascia Iliaca Block for Femoral Fracture Surgery Under General Anesthesia: A Dose-Finding Study (FIB-DEX)

Dexmedetomidine Added to Bupivacaine in Fascia Iliaca Block Combined With General Anesthesia for Femoral Fracture Surgery: A Dose-Finding Randomized Double-Blind Study

Sponsor
Cairo University (Academic or other)
Enrollment
90 planned
Conditions
Fracture Femur; Dexmedetomidine Analgesia; Fascia Iliaca Block
Interventions
Dexmedetomidine 0.5 ug/kg; Dexmedetomidine 0.75 mcg/kg; Dexmedetomidine 1 mcg/kg
Ages
adults, older adults
Registry
NCT07948720

Full record on ClinicalTrials.gov

From the registry

\### Brief Summary Femoral fractures can cause severe pain during and after surgery. Although fascia iliaca block is commonly used to relieve pain in patients undergoing femoral fracture surgery, the duration of pain relief may be limited. Dexmedetomidine is a medication that may prolong the pain-relieving effect of local anesthetics such as bupivacaine. However, the most appropriate dose of dexmedetomidine for this type of nerve block is not yet clearly established. This study aims to determine the lowest effective dose of dexmedetomidine when added to bupivacaine for ultrasound-guided fascia iliaca block in patients undergoing femoral fracture surgery under general anesthesia. The study includes 90 adult patients, aged 18-75 years, who are scheduled for femoral fracture surgery. Participants will be randomly assigned to one of three groups, with 30 patients in each group. All patients will receive general anesthesia and an ultrasound-guided fascia iliaca block containing 30 mL of 0.25% bupivacaine, combined with one of the following doses of dexmedetomidine: * Group A: 0.5…

Primary outcomes

  • Time to the first request for rescue analgesia in minutes

History

  1. Study completion expected

  2. Primary completion expected

  3. Expected to start

  4. Registered